Clinical trial
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow…
NCT00003538 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00003538 |
|---|---|
| Title | Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation |
| Official title | Stem Cell Augmented, Elutriated Grafts for Allogeneic Bone Marrow Transplantation |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological, Procedure |
| Interventions | graft versus host disease prophylaxis/therapy, allogeneic bone marrow transplantation |
| Start date | Mar 1, 1997 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | May 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: